Scientists probe blood clot risk of new Women's health drug
NCT ID NCT07173127
Summary
This study aims to understand if a medication called Ryeqo, used to treat uterine fibroids and endometriosis, affects the body's blood clotting system. Researchers will measure specific blood markers in 30 women before they start the drug and again after 3 months of use. The goal is to better estimate the potential risk of serious blood clots, helping doctors prescribe it more safely based on a woman's personal health history.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UTERINE FIBROID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpitaux Universitaires de Genève
RECRUITINGGeneva, Canton of Geneva, 1205, Switzerland
Contact
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.